Generally, yes: Rituxan (rituximab) is an antibody that binds the surface of B lymphocytes, which includes hairy cell leukemia. By itself it can induce remissions, but it is more effective when given in combination with other agents. Here is a link to a recent paper: http://www.ncbi.nlm.nih.gov/pubmed/25195120
Answered 8/29/2017
3.4k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question